Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2025 ∙ Robitaille, J. Esser, K. King, C. Leask, J. Wiley, K. Vigod, S. Rodin, G. Bolotin, S. Shapiro, G. K.

The Relationship Between Postpartum Depression and Timely Child Vaccination: A Systematic Review

  • Newborn
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ali Sheikhi, R. Heidari, M. Doosti, P.

The role of religious leaders in the acceptance of COVID-19 vaccinations: a systematic review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Shuai, T. Dong, M. Wu, P. Zhang, L. Feng, Z. Li, W. Liu, J.

The safety and efficacy of non-typeable Haemophilus influenzae and Moraxella catarrhalis vaccine in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials

  • All age groups
  • Haemophilus influenzae type B
  • Moraxella catarrhalis
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Valdecantos, R. L. Sorrentino, M. Mercogliano, M. Giordano, V. Trama, U. Triassi, M. Palladino, R.

The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review

  • Europe
  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Zhang, X. Zhao, T. Xie, T. Zhang, S. Xu, Q. Cheng, Y. Wei, H. He, A. Liu, B. Lu, Q. B. Jiang, Y. Cui, F.

Tracking the progress of maternal pertussis vaccination coverage among upper-middle- and high-income countries and territories - a systematic review and modeling study

  • Pregnant women
  • Pertussis
  • Coverage
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.

Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Gloeck, N. R. Leong, T. D. Mthethwa, M. Iwu-Jaja, C. J. Katoto, Pdmc Wiysonge, C. S. Kredo, T.

Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Typhoid
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.

Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines

  • Pregnant women
  • Newborn
  • Children
  • Adolescents
  • Chikungunya
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ojumu, A. Ibrahim, S. A. Seale, A. C. Fayehun, O. Gill, P.

Understanding factors influencing the implementation and uptake of less-established adult vaccination programmes: A meta-ethnography of COVID-19 vaccination in Nigeria

  • Africa
  • Nigeria
  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Satyam, S. M. El-Tanani, M. Bairy, L. K. Rehman, A. Srivastava, A. Kenneth, J. M. Prem, S. M.

Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...